BioReference Laboratories Inc. in Elmwood Park acquired the U.S. Ariosa centralized laboratory prenatal testing business from Roche. The Harmony Prenatal Test, Ariosa’s non-invasive prenatal screening ...
ELMWOOD PARK, N.J., July 20, 2020 /PRNewswire/ -- BioReference Laboratories, Inc., an OPKO Health company (NASDAQ: OPK), today announced it will accept an Indefinite Delivery Indefinite Quantity (IDIQ ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Similar to BioReference's role as the testing provider for the MLS is Back Tournament, BioReference is providing laboratory-based PCR COVID-19 testing as well as point-of-care (rapid) COVID-19 testing ...
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min Labcorp continues string of ...
Moreover, BioReference Laboratories also awaits an emergency use authorization (EUA) for its COVID-19 test from the FDA. Market Prospects A report by MarketsandMarkets projects the global infectious ...
(MENAFN- GlobeNewsWire - Nasdaq) ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE) -- BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the ...
ELMWOOD PARK, N.J., April 30, 2026 (GLOBE NEWSWIRE)-- BioReference® Health LLC, an OPKO Health, Inc. company and a trusted provider of diagnostic testing in the United States, today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results